Temperature-dependent production of pseudoinfectious dengue reporter virus particles by complementation

Virology

Volumn 381, Issue 1, 2008, Pages 67-74

  Ansarah Sobrinho, Camilo ^a   Nelson, Steevenson ^a   Jost, Christiane A ^a   Whitehead, Stephen S ^a   Pierson, Theodore C ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Antibody mediated neutralization; Dengue; Flavivirus; Reporter virus; West Nile virus

Indexed keywords

ARTICLE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; GENETIC COMPLEMENTATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; TEMPERATURE DEPENDENCE; VIRUS NEUTRALIZATION; VIRUS REPLICATION; WEST NILE FLAVIVIRUS;

ANIMALS; CERCOPITHECUS AETHIOPS; DENGUE; DENGUE VIRUS; GENETIC COMPLEMENTATION TEST; HUMANS; K562 CELLS; NEUTRALIZATION TESTS; TEMPERATURE; VERO CELLS; VIRION; VIRUS REPLICATION; WEST NILE VIRUS;

DENGUE VIRUS; FLAVIVIRUS; WEST NILE VIRUS;

EID: 54049109927     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.08.021     Document Type: Article

References (56)

1. Alvarez M., Rodriguez-Roche R., Bernardo L., Vazquez S., Morier L., Gonzalez D., Castro O., Kouri G., Halstead S.B., and Guzman M.G. Dengue hemorrhagic fever caused by sequential dengue 1-3 virus infections over a long time interval: Havana epidemic, 2001-2002. Am. J. Trop. Med. Hyg. 75 6 (2006) 1113-1117
2. Anderson R. Manipulation of cell surface macromolecules by flaviviruses. Adv. Virus Res. 59 (2003) 229-274
3. Andrewes C.H.a.E., and W.J. Observations on anti-phage sera. I. 'The percentage law'. Br. J. Exp. Pathol. 14 (1933) 367-376
4. Blaney Jr. J.E., Hanson C.T., Hanley K.A., Murphy B.R., and Whitehead S.S. Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2. BMC. Infect Dis. 4 (2004) 39
5. Clyde K., Kyle J.L., and Harris E. Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J. Virol. 80 23 (2006) 11418-11431
6. Davis C.W., Mattei L.M., Nguyen H.Y., Ansarah-Sobrinho C., Doms R.W., and Pierson T.C. The Location of asparagine-linked glycans on West Nile virions controls their interactions with CD209 (dendritic cell-specific ICAM-3 grabbing nonintegrin). J. Biol. Chem. 281 48 (2006) 37183-37194
7. Davis C.W., Nguyen H.Y., Hanna S.L., Sanchez M.D., Doms R.W., and Pierson T.C. West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection. J. Virol. 80 3 (2006) 1290-1301
8. Diamond M.S., Edgil D., Roberts T.G., Lu B., and Harris E. Infection of human cells by dengue virus is modulated by different cell types and viral strains. J. Virol. 74 17 (2000) 7814-7823
9. Endy T.P., Nisalak A., Chunsuttitwat S., Vaughn D.W., Green S., Ennis F.A., Rothman A.L., and Libraty D.H. Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. J. Infect Dis. 189 6 (2004) 990-1000
10. Fayzulin R., Scholle F., Petrakova O., Frolov I., and Mason P.W. Evaluation of replicative capacity and genetic stability of West Nile virus replicons using highly efficient packaging cell lines. Virology 351 1 (2006) 196-209
11. Gehrke R., Ecker M., Aberle S.W., Allison S.L., Heinz F.X., and Mandl C.W. Incorporation of tick-borne encephalitis virus replicons into virus-like particles by a packaging cell line. J. Virol. 77 16 (2003) 8924-8933
12. Geiss B.J., Pierson T.C., and Diamond M.S. Actively replicating West Nile virus is resistant to cytoplasmic delivery of siRNA. Virol. J. 2 (2005) 53
13. Goto A., Yoshii K., Obara M., Ueki T., Mizutani T., Kariwa H., and Takashima I. Role of the N-linked glycans of the prM and E envelope proteins in tick-borne encephalitis virus particle secretion. Vaccine 23 23 (2005) 3043-3052
14. Gubler D.J., and Meltzer M. Impact of dengue/dengue hemorrhagic fever on the developing world. Adv. Virus Res. 53 (1999) 35-70
15. Gubler D., K.G., and Markoff L. Flaviviruses. In: H.P., Knipe D.M., Griffin D.E., Lamb R.A., and Martin M.A. (Eds). Fields Virology. 5th 1 (2007), Lippincott Wlliams & Wilkins, Philadelphia 1153-1252 2 vols.
16. Halstead S.B. Neutralization and antibody-dependent enhancement of dengue viruses. Adv. Virus Res. 60 (2003) 421-467
17. Hanna S.L., Pierson T.C., Sanchez M.D., Ahmed A.A., Murtadha M.M., and Doms R.W. N-linked glycosylation of West Nile virus envelope proteins influences particle assembly and infectivity. J. Virol. 79 21 (2005) 13262-13274
18. Harvey T.J., Liu W.J., Wang X.J., Linedale R., Jacobs M., Davidson A., Le T.T., Anraku I., Suhrbier A., Shi P.Y., and Khromykh A.A. Tetracycline-inducible packaging cell line for production of flavivirus replicon particles. J. Virol. 78 1 (2004) 531-538
19. Hayasaka D., Yoshii K., Ueki T., Iwasaki T., and Takashima I. Sub-genomic replicons of Tick-borne encephalitis virus. Arch. Virol. 149 6 (2004) 1245-1256
20. Houng H.S., Chung-Ming Chen R., Vaughn D.W., and Kanesa-thasan N. Development of a fluorogenic RT-PCR system for quantitative identification of dengue virus serotypes 1-4 using conserved and serotype-specific 3′ noncoding sequences. J. Virol. Methods 95 1-2 (2001) 19-32
21. Jones C.T., Patkar C.G., and Kuhn R.J. Construction and applications of yellow fever virus replicons. Virology 331 2 (2005) 247-259
22. Khromykh A.A., and Westaway E.G. Subgenomic replicons of the flavivirus Kunjin: construction and applications. J. Virol. 71 2 (1997) 1497-1505
23. Khromykh A.A., Kenney M.T., and Westaway E.G. trans-Complementation of flavivirus RNA polymerase gene NS5 by using Kunjin virus replicon-expressing BHK cells. J. Virol. 72 9 (1998) 7270-7279
24. Khromykh A.A., Varnavski A.N., and Westaway E.G. Encapsidation of the flavivirus kunjin replicon RNA by using a complementation system providing Kunjin virus structural proteins in trans. J. Virol. 72 7 (1998) 5967-5977
25. Kinney R.M., Butrapet S., Chang G.J., Tsuchiya K.R., Roehrig J.T., Bhamarapravati N., and Gubler D.J. Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53. Virology 230 2 (1997) 300-308
26. Klasse P.J., and Sattentau Q.J. Mechanisms of virus neutralization by antibody. Curr. Top Microbiol. Immunol. 260 (2001) 87-108
27. Lai C.Y., Hu H.P., King C.C., and Wang W.K. Incorporation of dengue virus replicon into virus-like particles by a cell line stably expressing precursor membrane and envelope proteins of dengue virus type 2. J. Biomed. Sci. 15 1 (2008) 15-27
28. Lindenbach B.D., Thiel H.J., and Rice C.M. Flaviviridae: the viruses and their replication. In: H.P.M. D.M., Knipe, Griffin D.E., Lamb R.A., and Martin M.A. (Eds). Fields Virology. 5th 1 (2007), Lippincott Williams & Wilkins, Philadelphia 1101-1152 2 vols.
29. Mackenzie J.S., Gubler D.J., and Petersen L.R. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat. Med. 10 12 Suppl (2004) S98-109
30. Mehlhop E., Ansarah-Sobrinho C., Johnson S., Engle M., Fremont D.H., Pierson T.C., and Diamond M.S. Complement protein C1q inhibits antibody-dependent enhancement of flavivirus infection in an IgG subclass-specific manner. Cell Host Microbe 2 6 (2007) 417-426
31. Molenkamp R., Kooi E.A., Lucassen M.A., Greve S., Thijssen J.C., Spaan W.J., and Bredenbeek P.J. Yellow fever virus replicons as an expression system for hepatitis C virus structural proteins. J. Virol. 77 2 (2003) 1644-1648
32. Monath T.P. Dengue and yellow fever-challenges for the development and use of vaccines. N. Engl. J. Med. 357 22 (2007) 2222-2225
33. Mongkolsapaya J., Dejnirattisai W., Xu X.N., Vasanawathana S., Tangthawornchaikul N., Chairunsri A., Sawasdivorn S., Duangchinda T., Dong T., Rowland-Jones S., Yenchitsomanus P.T., McMichael A., Malasit P., and Screaton G. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat. Med. 9 7 (2003) 921-927
34. Navarro-Sanchez E., Altmeyer R., Amara A., Schwartz O., Fieschi F., Virelizier J.L., Arenzana-Seisdedos F., and Despres P. Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO. Rep. 4 7 (2003) 723-728
35. Nelson S., Jost C.A., Xu Q., Ess J., Martin J.E., Oliphant T., Whitehead S.S., Durbin A.P., Graham B.S., Diamond M.S., and Pierson T.C. Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization. PLOS Pathogens 4 (2008) e1000060
36. Oliphant T., Nybakken G.E., Engle M., Xu Q., Nelson C.A., Sukupolvi-Petty S., Marri A., Lachmi B.E., Olshevsky U., Fremont D.H., Pierson T.C., and Diamond M.S. Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein. J. Virol. 80 24 (2006) 12149-12159
37. Oliphant T., Nybakken G.E., Austin S.K., Xu Q., Bramson J., Loeb M., Throsby M., Fremont D.H., Pierson T.C., and Diamond M.S. Induction of epitope-specific neutralizing antibodies against West Nile virus. J. Virol. 81 21 (2007) 11828-11839
38. Pang X., Zhang M., and Dayton A.I. Development of Dengue virus type 2 replicons capable of prolonged expression in host cells. B.M.C. Microbiol. 1 (2001) 18
39. Pierson T.C., Diamond M.S., Ahmed A.A., Valentine L.E., Davis C.W., Samuel M.A., Hanna S.L., Puffer B.A., and Doms R.W. An infectious West Nile virus that expresses a GFP reporter gene. Virology 334 1 (2005) 28-40
40. Pierson T.C., Sanchez M.D., Puffer B.A., Ahmed A.A., Geiss B.J., Valentine L.E., Altamura L.A., Diamond M.S., and Doms R.W. A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection. Virology 346 1 (2006) 53-65
41. Pierson T.C., Xu Q., Nelson S., Oliphant T., Nybakken G.E., Fremont D.H., and Diamond M.S. The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection. Cell Host Microbe 1 2 (2007) 135-145
42. Rothman A.L. Dengue: defining protective versus pathologic immunity. J. Clin. Invest. 113 7 (2004) 946-951
43. Sanchez M.D., Pierson T.C., McAllister D., Hanna S.L., Puffer B.A., Valentine L.E., Murtadha M.M., Hoxie J.A., and Doms R.W. Characterization of neutralizing antibodies to West Nile virus. Virology 336 1 (2005) 70-82
44. Sanchez M.D., Pierson T.C., Degrace M.M., Mattei L.M., Hanna S.L., Del Piero F., and Doms R.W. The neutralizing antibody response against West Nile virus in naturally infected horses. Virology 359 2 (2007) 336-348
45. Scholle F., Girard Y.A., Zhao Q., Higgs S., and Mason P.W. trans-Packaged West Nile virus-like particles: infectious properties in vitro and in infected mosquito vectors. J. Virol. 78 21 (2004) 11605-11614
46. Shi P.Y., Tilgner M., and Lo M.K. Construction and characterization of subgenomic replicons of New York strain of West Nile virus. Virology 296 2 (2002) 219-233
47. Stephens H.A., Klaythong R., Sirikong M., Vaughn D.W., Green S., Kalayanarooj S., Endy T.P., Libraty D.H., Nisalak A., Innis B.L., Rothman A.L., Ennis F.A., and Chandanayingyong D. HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens 60 4 (2002) 309-318
48. Tassaneetrithep B., Burgess T.H., Granelli-Piperno A., Trumpfheller C., Finke J., Sun W., Eller M.A., Pattanapanyasat K., Sarasombath S., Birx D.L., Steinman R.M., Schlesinger S., and Marovich M.A. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med. 197 7 (2003) 823-829
49. Varnavski A.N., Young P.R., and Khromykh A.A. Stable high-level expression of heterologous genes in vitro and in vivo by noncytopathic DNA-based Kunjin virus replicon vectors. J. Virol. 74 9 (2000) 4394-4403
50. Vaughn D.W., Green S., Kalayanarooj S., Innis B.L., Nimmannitya S., Suntayakorn S., Endy T.P., Raengsakulrach B., Rothman A.L., Ennis F.A., and Nisalak A. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J. Infect Dis. 181 1 (2000) 2-9
51. Whitby K., Pierson T.C., Geiss B., Lane K., Engle M., Zhou Y., Doms R.W., and Diamond M.S. Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo. J. Virol. 79 14 (2005) 8698-8706
52. Whitehead S.S., Falgout B., Hanley K.A., Blaney Jr. J.E., Markoff L., and Murphy B.R. A live, attenuated dengue virus type 1 vaccine candidate with a 30-nucleotide deletion in the 3′ untranslated region is highly attenuated and immunogenic in monkeys. J. Virol. 77 2 (2003) 1653-1657
53. Whitehead S.S., Blaney J.E., Durbin A.P., and Murphy B.R. Prospects for a dengue virus vaccine. Nat. Rev. Microbiol. 5 7 (2007) 518-528
54. WHO. Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control (1997), Geneva
55. Yoshii K., Hayasaka D., Goto A., Kawakami K., Kariwa H., and Takashima I. Packaging the replicon RNA of the Far-Eastern subtype of tick-borne encephalitis virus into single-round infectious particles: development of a heterologous gene delivery system. Vaccine 23 30 (2005) 3946-3956
56. Yoshii K., Goto A., Kawakami K., Kariwa H., and Takashima I. Construction and application of chimeric virus-like particles of tick-borne encephalitis virus and mosquito-borne Japanese encephalitis virus. J. Gen. Virol. 89 Pt 1 (2008) 200-211